In The News Posted July 25, 2019 Share Posted July 25, 2019 SAN FRANCISCO, July 24, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Karyopharm Therapeutics Inc.'s (NASDAQ: KPTI) April 28, 2017 and May 7, 2018 public offerings to the firm's investigation into possible securities law violations. If you purchased Karyopharm... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.